Evidence mapPaperPMID 41716964Full record

ReviewJournal of diabetes research2026

Protective Role of Physical Exercise and Exercise-Induced FNDC5/Irisin in Combating Diabetes-Related Cognitive Impairment and Autonomic and Peripheral Neuropathies: A Comprehensive Review.

Sepideh Poshtdar, Hosein Ataei-Goujani, Amirali Ahrabi

Abstract readReview
In one paragraph

Review in Journal of diabetes research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Sepideh PoshtdarSchool of Medicine, Tehran University of Medical Sciences, Tehran, Iran, tums.ac.ir.ORCID https://orcid.org/0009-0007-3552-4137
Hosein Ataei-GoujaniStudent Research Committee, Shahrekord University of Medical Sciences, Shahrekord, Iran, skums.ac.ir.ORCID https://orcid.org/0000-0003-0163-1077
Amirali AhrabiSchool of Medicine, Tehran University of Medical Sciences, Tehran, Iran, tums.ac.ir.ORCID https://orcid.org/0009-0004-6753-2703

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The rising prevalence of diabetes has been closely linked to increased mortality and morbidity, particularly as its complications become more widespread. Among the most challenging of these complications are cognitive impairments and diabetic neuropathies, which are neurodegenerative conditions that significantly diminish the quality of life in the diabetic population. Beyond its well-established benefits for improving glycemic control and preventing cardiovascular complications, physical exercise has also been shown to mitigate central and peripheral neurodegenerative complications of diabetes, including cognitive decline, peripheral neuropathies, and autonomic neuropathies. Emerging research suggests that fibronectin type III domain-containing protein 5 (FNDC5), later converted into irisin, an exercise-induced myokine, plays a key role in mediating these protective effects. This narrative review thoroughly examines the protective impact of various forms of physical exercise-including aerobic, resistance, and multimodal training-on diabetic neuropathies and cognitive decline, while also exploring the involvement of FNDC5/irisin in these beneficial outcomes across experimental animal studies, cross-sectional analyses, and controlled trials.

Indexed as

Autonomic Nervous System DiseasesCognitive DysfunctionDiabetic NeuropathiesExerciseFibronectinsAnimalsHumansMyokinesFibronectinsFNDC5 protein, humanMyokinesaerobic exercisecognitive impairmentdiabetes mellitusdiabetic neuropathyFNDC5irisinresistance training

Identifiers

PMID41716964
PMCPMC12914223

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.